Navigation Links
Halozyme's rHuPH20 With Recombinant Human Insulin Demonstrates Glycemic Control Comparable to Lispro
Date:11/12/2010

SAN DIEGO, Nov. 12, 2010 /PRNewswire-FirstCall/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) today announced Phase 2 results demonstrating that Insulin-PH20 (recombinant human insulin with rHuPH20) produced glycemic control comparable to lispro, a widely prescribed prandial (mealtime) insulin analog. The overall safety and adverse event profiles for the two agents were comparable and both treatments were well tolerated. Insulin-PH20 achieved the primary endpoint of non-inferiority for glycemic excursions relative to lispro alone in this study conducted in a take-home diabetes treatment setting. This study represents the first reported experience in a clinical trial where patients received Halozyme's recombinant human hyaluronidase enzyme, rHuPH20, three times daily for 12 weeks for a total of over 10,000 doses of enzyme with insulin. Halozyme presented these results today at the Diabetes Technology Society meeting in Bethesda, Md.

(Logo:  http://photos.prnewswire.com/prnh/20100302/LA63139LOGO)

(Logo:  http://www.newscom.com/cgi-bin/prnh/20100302/LA63139LOGO)

"Halozyme has demonstrated that the combination of its PH20 enzyme with recombinant human insulin accelerates the pharmacokinetic profile to that of the currently marketed prandial analogs. The combination produces treatment effects and a safety profile comparable to the analog insulin lispro," stated Doug Muchmore, M.D., vice president of endocrinology clinical development. "The glycemic excursion results, occurrence of hypoglycemia, and reported adverse events were comparable for the two test t
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Halozyme Therapeutics Begins Phase 1 Clinical Trial of Bisphosphonate Administered With rHuPH20 Enzyme
2. Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability
3. Halozyme Therapeutics Presents Findings on Combinations of rHuPH20 Enzyme With Bisphosphonates at the American Association for Cancer Research Conference
4. Halozyme Therapeutics Presents Pre-Clinical Studies of Systemic Delivery of Pegylated rHuPH20 Enyzme in Prostate Cancer Models at American Association for Cancer Research Conference
5. Octapharma Clinical Trial Begins in the U.S. and Germany Treating Hemophilia A Patients with First Recombinant Factor VIII Derived from a Human Cell-Line
6. Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Now Available at ReportsandReports
7. Pfenex Inc. Awarded Contract With the United States Federal Government Potentially Totaling Up to $18.8 Million to Develop a Robust Pfenex Expression Technology Based Process for the Production of Bulk Recombinant Protective Antigen (rPA) From Anthr
8. Bone Biologics Announces Another Major US Patent Issuance for Recombinant Protein Process
9. Repligen Receives Notice of Allowance for Recombinant Protein A Patent
10. Repligen Announces Long Term Supply Agreement with GE Healthcare for Recombinant Protein A
11. Octapharma Group and Fresenius Kabi Enter Into an Exclusive License, Development and Supply Agreement for a HESylated Recombinant Protein
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... August 29, 2014 According ... Market by Extraction type (SFE, Cold Pressed, Organic ... Care, Pharmaceutical, Food Supplements, Fragrance, & Others) - Global ... defines and segments the Amaranth Seed Oil Market ... size in terms of value. The Amaranth Seed ...
(Date:8/29/2014)... 29, 2014 Research and Markets ... Development Trend Forecast of Pharmaceutical Equipment Market in China, ... Research and Development Trend Forecast of Pharmaceutical Equipment Market ... China,s pharmaceutical equipment industry in ... competition landscape, and business performance of domestic major enterprises, ...
(Date:8/29/2014)...   Vittamed Corporation , a neurodiagnostics medical device company ... T. (Teo) Forcht Dagi , MD, DmedSc, MPH, MBA, ... " Teo Forcht Dagi is an ... and venture capital," said Remis Bistras , President and ... clinical, strategic, and entrepreneurial expertise to our Board." ...
Breaking Medicine Technology:Amaranth Seed Oil Market worth $700.6 Million by 2019 2Amaranth Seed Oil Market worth $700.6 Million by 2019 3Amaranth Seed Oil Market worth $700.6 Million by 2019 4Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2Vittamed Adds Prominent Neurosurgeon and Venture Capitalist T. Forcht Dagi to Board of Directors 2
... YORK, April 23, 2012  Delcath Systems, Inc. (NASDAQ: ... working capital line of credit revolver with Silicon Valley Bank ... sciences. The credit facility is available for general corporate purposes ... Commenting on the transaction, Eamonn P. Hobbs, President ...
... 21, 2012 Medaxial, the healthcare value ... Queen,s Award for Enterprise in recognition of its international ... are the UK,s most prestigious business accolade, bestowed by ... of companies who have achieved outstanding results in international ...
Cached Medicine Technology:Delcath Systems, Inc. Secures $20 Million Credit Facility 2Delcath Systems, Inc. Secures $20 Million Credit Facility 3Delcath Systems, Inc. Secures $20 Million Credit Facility 4Pharmaceutical Industry Service Company Awarded The UK's Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade 2Pharmaceutical Industry Service Company Awarded The UK's Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade 3
(Date:8/30/2014)... 30, 2014 According to Bloomberg ... that requires Takeda Pharmaceutical Co. and Eli Lilly & ... claims that the drugmakers concealed information about a risk ... The case, Allen v. Takeda Pharmaceuticals North America Inc. ... District of Louisiana (Lafayette).* , According to Bloomberg, Takeda ...
(Date:8/30/2014)... 2014 United Theological Seminary is pleased to ... the Master of Theological Studies (MTS). , ... designed for students who wish to pursue further academic study ... to serve the Church and community. Previously, students needed to ... can attend classes from any location where there is an ...
(Date:8/30/2014)... August 30, 2014 Daily Gossip magazine ... keeps anxiety and panic attacks under control with a ... program review describes this new method as an ... panic attacks and overcome general anxiety related disorders. ... is the fact that it can be accessed by ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 RB SEO ... cost SEO service for small businesses. , RBSEO Services ... cannot afford costly search engine optimization service. So, the ... small businesses into account. , On being asked ... have introduced this low cost SEO service because many ...
(Date:8/30/2014)... a common problem millions of American cope with every day. While ... for some, it can have a crippling impact on social activity ... mood swings and depression. , Those struggling with acne are ... some cases, that can make the problem even worse. Instead of ... quest for clearer skin can now view acne treatment reviews ...
Breaking Medicine News(10 mins):Health News:The Law Office of Melinda J. Helbock A.P.C. Comments on Decision to Uphold $9 Billion Actos Award 2Health News:United Theological Seminary Announces First Fully Online Degree 2Health News:Panic Away Review Reveals New Natural Remedy for Anxiety Patients 2Health News:RBSEO Services Introduces Low Cost SEO Service for Small Businesses 2Health News:Acne Treatment Reviews Added to Popular Treatment Website 2
... ATLANTA The context in which adolescent sexual ... between sexual intercourse and education, according to research ... of the American Sociological Association. "Compared to ... often academically harmless, whereas in other types of ...
... HealthDay Reporter , WEDNESDAY, Aug. 11 (HealthDay ... brain stimulation appeared to improve memory slightly in several ... that the findings are very preliminary and that "no ... However, test results and brain imaging suggest that the ...
... Mott HealthDay Reporter , FRIDAY, Aug. 13 (HealthDay News) ... he found an empty bottle of ibuprofen on the living room ... puppy, Otis, had knocked the pain-reliever container off the coffee table ... devoured dozens of the pills. "My heart dropped through the ...
... HealthDay Reporter , THURSDAY, Aug. 12 (HealthDay News) ... jams and work deadlines may depend, in part, on how ... suggests. "The message is that father-son relationships are incredibly ... study lead author Melanie Mallers, an assistant professor at California ...
... 12, 2010) The American Society of ... scientific community and federal agencies to help propel ... make real strides in improving patient care. These ... scientific journal, in the article titled " Enhancing ...
... An elevated resting heart rate that develops or persists during ... whether from heart disease or other causes, researchers from the ... Center found studying outcomes in more than 9,000 patients. , ... 2 online in the European Heart Journal , suggest ...
Cached Medicine News:Health News:Sex between adolescents in romantic relationships is often harmless to their academics 2Health News:Deep Brain Stimulation Studied for Alzheimer's 2Health News:Deep Brain Stimulation Studied for Alzheimer's 3Health News:Human Meds Are Pets' Biggest Poisoning Danger 2Health News:Human Meds Are Pets' Biggest Poisoning Danger 3Health News:Bond With Dad May Play Role in Whether Men 'Stress Out' 2Health News:ASH recommends cross-disciplinary engagement to advance regenerative medicine 2Health News:Elevated heart rate over time linked to significant risk of death 2Health News:Elevated heart rate over time linked to significant risk of death 3
... test kit is an enzyme immunometric ... with a liquid phase,incubation, designed for ... serum. The microplate is coated,with anti-rabbit ... to anti-rabbit antibody-coated wells, along with ...
Vitamin B6 Jumbo REA Vitamin Assays, Cardiovascular 001-RK-VB6N...
Myoglobin EIA Lipid / Protein Quantification, Cardiovascular 024-IDC-13 Muscle Disease...
IGF-BP3 EIA Endocrine Function 022-IGF-E03 Insulin Growth Factor binding protein...
Medicine Products: